Skip to main content Skip to main content
Not investment advice. Educational platform. See Disclaimer.
OTC: ACBM

Acro Biomedical Co., Ltd.

Healthcare | Biotechnology
$0.03 +0.00 (+0.00%) as of 2026-07-14 13:04 UTC
Volume260

Acro Biomedical Co., Ltd. (OTC: ACBM) is a biotechnology company trading at $0.03. Figures from SEC EDGAR and market feeds; updated 2026-07-14 13:04 UTC.

52-Week Range
Low $0.00High $0.10

What Acro Biomedical Co., Ltd. does

Since a change of control in January 2017, the company has developed and marketed nutritional products focused on wellness, primarily cordyceps-related products sourced from suppliers in Taiwan. Cordyceps is a fungus used in traditional Chinese medicine found at high altitudes. The company previously sold one other product, metallothionein MT-3 elixir, and has explored a cordyceps-based chicken feed but currently has no active operations.

Summarized from Acro Biomedical Co., Ltd.’s SEC filings · Read the filing ↗

Key facts
Quote
Price$0.03
Change (1D)+0.00 (+0.00%)
Volume260 shares
52-week range$0.00 – $0.10
Valuation
Return on equity26.14%
Returns
52-week return+3614.3%
Revenue, margins & earnings
FY2021: net loss $8M on revenue $1M$1MFY2021FY2022: net loss $16M on revenue $658,500$658,500FY2022
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
  • Net loss year
Annual revenue; bands show net, operating, gross margins · Open in Platform →
SEC Filings SEC EDGAR ↗
No filings archived yet. Search EDGAR ↗
Recent Insider Activity
No insider transactions on file with the SEC for ACBM.
Source: SEC EDGAR · Last checked 2026-07-14
Top Institutional Holders (latest 13F)
No 13F filings reference ACBM in the last quarter.
Source: SEC EDGAR · Last checked 2026-07-14
Company news View all →
No qualifying company news in the archive. Full tape in the platform →
Questions this page answers

What does Acro Biomedical Co., Ltd. do?

Since a change of control in January 2017, the company has developed and marketed nutritional products focused on wellness, primarily cordyceps-related products sourced from suppliers in Taiwan.

What is ACBM's valuation?

ACBM trades at $0.03, as of 2026-07-14.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-07-14 13:04 UTC. This page is also available as JSON at /api/data?ticker=ACBM and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for ACBM and 3,500+ tickers.

Create a free account — keep ACBM
For your agent
GET /api/data?ticker=ACBM

This page as JSON via rel="alternate" · REST API docs · MCP server (51 tools) · llms.txt